Fierce Pharma

FEBRUARY 16, 2024

The T-cell therapy treatment class, which has transformed the treatment of certain blood cancers, has now reached the solid tumor field thanks to an FDA approval for a first-of-its-kind immunothera | The T-cell therapy treatment class, which has transformed the treatment of certain blood cancers, has now reached the solid tumor field thanks to an FDA approval for a first-of-its-kind immunotherapy developed by Iovance Biotherapeutics.

FDA 346

FDA 346

Clarivate

FEBRUARY 16, 2024

New – unified rankings for each of our 229 science and social science categories; no Journal Impact Factor (JIF) rankings for the arts and humanities categories The scholarly landscape is witnessing a significant increase in both the quantity and sophistication of fraudulent behaviors, posing a substantial threat to the integrity of the scholarly record.

Distribution 141

Distribution Consulting Government 141

Fierce Pharma

FEBRUARY 16, 2024

People with food allergies finally have a drug that can help prevent severe outcomes—and it’s a drug that’s been on the market for two decades. | People with food allergies finally have a drug that can help prevent severe outcomes—and it’s a drug that’s been on the market for two decades. The FDA has blessed Roche and Novartis’ Xolair as the first medicine to reduce allergic reactions that can occur with accidental exposure to certain foods.

Food 324

Food FDA Medicine Marketing 324

MedCity News

FEBRUARY 16, 2024

A new EY survey found that while 86% of health executives say that digital health solutions have the potential to reduce costs, 70% said they haven’t seen a return on investment so far.

114

114

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

FEBRUARY 16, 2024

Gene editing’s therapeutic application has transitioned from hypothetical to reality, marked by the recent approval of a CRISPR-based therapy for sickle cell and beta thalassemia. | This week on "The Top Line," Max Bayer from Fierce Biotech explores the future of gene editing in an interview with the CEO of Verve Therapeutics.

302

302

MedCity News

FEBRUARY 16, 2024

Offering safe affordable family-forming programs for everyone, including vulnerable or under-served employee populations, represents an opportunity for employers to build a caring culture that also will benefit the bottom line.

Competition 114

Competition 114

MedCity News

FEBRUARY 16, 2024

As more and more organizations integrate Generative AI with Configure, Price, Quote (CPQ) systems, they declare their belief that we can aspire to incredible advancements in human health and well-being through digital transformation.

Healthcare 113

Healthcare Healthcare 113

Fierce Pharma

FEBRUARY 16, 2024

While Johnson & Johnson’s consumer health spinoff Kenvue prepares to move into a swanky new headquarters in Summit, New Jersey, it appears some staffers won’t be joining the company in the tran | While Johnson & Johnson’s consumer health spinoff Kenvue prepares to move into a new headquarters in Summit, New Jersey, it appears some staffers won’t be joining the company in the transition.

252

252

pharmaphorum

FEBRUARY 16, 2024

CAR-T therapies can achieve remarkable efficacy in the treatment of haematological cancers, but the risk of side effects means that the cell infusions are almost always administered to inpatients under close supervision in clinics.

Side effects 119

Side effects Safety 119

Fierce Pharma

FEBRUARY 16, 2024

Four months after the FDA rejected Sanofi and Regeneron’s Dupixent to treat chr | Four months after the FDA rejected Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria, Japan’s health regulators have signed off on the drug in the indication.

FDA 213

FDA 213

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

FEBRUARY 16, 2024

Astellas Pharma is working with Kelonia Therapeutics, a startup that develops in vivo CAR T-therapies with technology that precisely delivers genetic cargo to cells. The collaboration combines this tech with a platform from Xyphos Biosciences, a cell therapy developer that Astellas acquired in 2019.

Pharma 108

Pharma Biopharma 108

Fierce Pharma

FEBRUARY 16, 2024

After Elevidys scored an FDA approval in a restricted group of patients, Sarepta's attempt for a larger indication has snared a priority review.

FDA 166

FDA Patients 166

MedCity News

FEBRUARY 16, 2024

Moving from spreadsheets to automated data collection and processing is far from easy, but it could revolutionize drug development. It’s time for the biopharma industry to embrace end-to-end digitalization.

Biopharma 106

Biopharma 106

Fierce Pharma

FEBRUARY 16, 2024

The scientific community has made tremendous progress against viral diseases.

136

136

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

FEBRUARY 16, 2024

Recent biotech financings include a $245m raise for cancer blood test company Freenome, plus big rounds for Cogent Biosciences, BioAge Labs, Latigo Biotherapeutics, ProfoundBio, and Firefly Bio

119

119

European Pharmaceutical Review

FEBRUARY 16, 2024

Researchers have highlighted the potential of end-to-end continuous manufacture with column-free capture alternatives. The traditional batch process was compared with end-to-end continuous bioprocesses with either protein A (ProA) capture or column-free capture, employing aqueous two-phase extraction (ATPE) or precipitation from economic, environmental, and robustness perspectives.

Manufacturing 97

Manufacturing Biopharma Pharmaceutical Marketing 97

pharmaphorum

FEBRUARY 16, 2024

Gilead Sciences has paused enrolment in clinical trials of its CD47 drug magrolimab in solid tumours, a week after dropping it for blood cancers.

124

124

MedCity News

FEBRUARY 16, 2024

Elation Health integrated Surescripts’ real-time prescription benefit tool — which gives clinicians immediate access to patient-specific medication coverage and cost data — into its EHR. The partnership aims to improve patients’ medication adherence by helping primary care physicians have more meaningful conversations with their patients about prescription affordability during visits.

Prescription 98

Prescription Physicians Medical Patients 98

Advertisement

pharmaphorum

FEBRUARY 16, 2024

Astellas has signed a deal with Kelonia Therapeutics that aims to push the boundaries of what can be achieved with CAR-T therapies in immuno-oncology

121

121

MedCity News

FEBRUARY 16, 2024

Equal parts networking and curated panels covering the latest trends in healthcare investment, MedCity INVEST 2024 is the ideal event to discuss health tech, biopharma, devices and diagnostics investment opportunities. Register today!

Healthcare 95

Healthcare Healthcare Biopharma Networking 95

Pharmaceutical Technology

FEBRUARY 16, 2024

This positive news comes after Otsuka’s Phase III Alzheimer’s agitation trial failed to meet its primary endpoint, announced earlier this week.

FDA 98

FDA 98

Impetus Digital

FEBRUARY 16, 2024

A version of this article was previously published on PharmaPhorum. Whether we’re talking offices, medical congresses, or advisory board meetings , the term “hybrid” is often used to signal the ideal state. The place where everyone’s needs are being met. The best of both worlds. In the era of digital transformation, it is predicted that 2024 will be the year that finally cements hybrid meetings as the norm (1), with all-virtual meetings continuing to be a popular option.

Pharma 85

Pharma Healthcare Provider Healthcare Healthcare 85

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmaceutical Technology

FEBRUARY 16, 2024

GSK has successfully concluded the acquisition of Aiolos Bio in a deal that could reach $1.4bn, expanding its respiratory portfolio.

95

95

Pharmaceutical Commerce

FEBRUARY 16, 2024

The financial commitment features construction of new warehouses in Pennsylvania and North Carolina.

Healthcare 103

Healthcare Healthcare 103

PharmaTimes

FEBRUARY 16, 2024

Cardiac quantitative susceptibility mapping successfully visualised iron deposits in patients

Patients 93

Patients 93

PharmaVoice

FEBRUARY 16, 2024

Belt tightening and streamlined portfolios are critical in 2024 amid continued economic uncertainty.

Pharma 86

Pharma 86

Advertisement

Distribution

PharmaTimes

FEBRUARY 16, 2024

NRTX-1001 is being assessed for drug-resistant mesial temporal lobe epilepsy

Leads 91

Leads 91

PharmExec

FEBRUARY 16, 2024

Novartis’ and Roche’s Xolair (omalizumab) is indicated to treat severe allergic reactions after accidental exposure to one or more foods in individuals aged one year and above.

Food 52

Food Patients FDA 52

Rep-Lite

FEBRUARY 16, 2024

In healthcare, knowing how to grow a sales team can facilitate the success of any healthcare organization. The medical sales industry covers several sub-categories including, medical device sales rep, pharmaceutical sales rep, and medtech sales. Medical sales representatives build trust with medical professionals and offer insights into health care while navigating regulations.

Medical sales 52

Medical sales Sales Medical Medical sales reps 52

Pharmaceutical Commerce

FEBRUARY 16, 2024

Xolair (omalizumab) was previously granted FDA Priority Review status and Breakthrough Therapy Designation to prevent severe allergic reactions after accidental exposure to one or more foods in people with allergies.

Food 52

Food FDA 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales